The transcription factor E2F-1 induces cell cycle progression at the G1/S checkpoint, and deregulation of E2F-1 provokes apoptosis in a wide variety of malignant cells. To date only p14 ARF and p73, a p53 homologue, have been identified as E2F-1-inducible genes capable of mediating an apoptotic response. Here we show that adenovirus-mediated E2F-1 overexpression in cancer cells induces expression and autophosphorylation of the double-stranded RNA-dependent protein kinase PKR leading to phosphorylation of its downstream target, the a-subunit of the eukaryotic translation initiation factor 2 (eIF-2a) and to apoptotic cell death. This PKR-dependent apoptosis occurs in cell lines with mutated p53 and in cell lines with mutated p53 and p73, and is significantly reduced by the chemical inhibition of PKR activation. Further, PKR 7/7 mouse embryo fibroblasts, but not PKR +/+ mouse embryo fibroblasts, demonstrate significant resistance to E2F-1-induced apoptosis. We conclude that an important pathway of E2F-1-mediated apoptosis is dependent on PKR activation and does not require p53 or p73.
Introduction
E2F-1 is a member of a family of transcription factors that play a key role in control of cell proliferation by linking the activities of the cell cycle machinery with the transcriptional regulation of genes required for S phase entry and DNA synthesis. Although all the E2F transcription factors can induce proliferation and differentiation, only E2F-1 is known to effectively induce a broad variety of tumor cells to undergo programmed cell death (apoptosis) (Adams and Kaelin, 1996; Aktas et al., 1998; DeGregori et al., 1997; Field et al., 1996; Hsieh et al., 1997; Hunt et al., 1997; Kowalik et al., 1998; Phillips et al., 1997; Shan et al., 1996; Wang et al., 2000) . The mechanism by which E2F-1 induces apoptosis has not been fully elucidated, but at least two distinct pathways seem to play a role in cancer cells: a p53-dependent pathway by activation of p14 ARF , which binds to MDM2 and prevents p53 degradation, and a p53-independent alternative pathway, which includes the p53 homologue p73. Among more than 1240 genes that have been found to be significantly altered after E2F activation, only p53 and p73 have been verified to be E2F-1-inducible genes capable of mediating an apoptotic response (Bates et al., 1998; Irwin et al., 2000) . Even though effector caspase-3 and cytochrome c binding protein APAF1, both relevant in apoptosis, have also been shown to be upregulated by E2F-1, similar expression patterns were induced by nonapoptotic E2F family members (Muller et al., 2001) . The double-stranded RNA-dependent protein kinase PKR was first identified as a mediator of the antiproliferative and antiviral actions of interferon (Katze, 1992; Samuel, 1992) . PKR can be activated by viruses, which produce a variety of types of double-stranded RNA, and by various other agents, including interleukins, interferons, heparin, tumor necrosis factor-a, bacterial lipopolysaccharides and the recently discovered activator protein PACT/RAX (Patel and Sen, 1998; Ito et al., 1999) . These agents induce a conformational change in the latent form of PKR, which is present at low constitutive levels in a large variety of mammalian cells (Aktas et al, 1998; Carpick et al., 1997; Chong et al., 1992; Dever et al., 1993; Gusella et al., 1995; Hovanessian and Galabrul, 1987; Ito et al., 1999; Patel et al., 2000; Prostko et al., 1995; Yeung et al., 1996) . Once activated, PKR homodimerizes and phosphorylates itself and its target substrates, including the a-subunit of the eukaryotic translation initiation factor 2 (eIF-2a) (Kumar et al., 1994; Pain, 1996; Samuel, 1993; Yang et al., 1995) . Phosphorylation of eIF-2a by PKR increases the affinity of GDP to the eIF-heterodimer 100-fold such that GDP-GDP exchange, necessary for the initiation of translation by the tRNA-40S ribosomal subunit, is inhibited. This leads to inhibition of cellular as well as viral protein synthesis; growth suppression; and apoptotic cell death. PKR is also involved in the regulation of several other transcription factors, including NF-kB, interferon regulating factor-1, p53, and STAT1, which have been shown to play a crucial role in cell growth, differentiation, proliferation, and induction of apoptosis in a variety of different tumor cell lines (Cuddihy et al., 1999; Kumar et al., 1997; Patel and Sen, 1998; Patel et al., 1999; Wong et al., 2001) .
Previous studies showed that the promoter region of PKR has a distinct E2F-1 binding site that overlaps a portion of the interferon-stimulated response element of PKR Samuel, 1994, 2000) . We have previously reported that adenovirus-mediated E2F-1 overexpression induces apoptosis in cancer cell lines with mutated p53 and/or silenced p73 (Hunt et al., 1997) . We evaluated whether PKR plays a role in E2F-1-induced apoptosis in cells with mutated p53 and p73. We report in this study that adenovirus-mediated overexpression of E2F-1 induces PKR upregulation, PKR activation, eIF-2a phosphorylation, and apoptosis independent of the p53 or p73 status of the cells. Absence or inhibition of PKR leads to significantly decreased sensitivity to E2F-1-induced apoptosis. These results suggest a novel role of PKR as a mediator of E2F-1-induced apoptosis.
Results

E2F-1 induces PKR upregulation and apoptosis in various tumor cell lines
We used a replication-deficient human type 5 adenovirus with the E1A region replaced with the E2F-1 gene (Ad5E2F) or replaced with the non-toxic reporter Luciferase gene (Ad5Luc) as a control. After infection with Ad5E2F at a multiplicity of infection of 200 plaque-forming units per cell, growth curves of SW620, SW480, and KM12L4 colon carcinoma cells and MDA-MB-468 breast cancer cells showed significantly inhibited proliferation and increased cell death. Treatment with Ad5Luc and PBS did not inhibit cell growth. Propidium iodide staining and flow cytometric cell cycle analysis was performed 24, 36, and 72 h following infection. Significantly increased levels of subdiploid cell populations, a hallmark of apoptosis and DNA oligonucleosomal fragmentation (DNA laddering) was seen in Ad5E2F-treated cells compared with control cells in all cell lines except the MCF-7 breast cancer cell line (Figure 1 ). In Ad5E2F-treated cell cultures, morphologic changes in the cells were consistent with apoptotic cell death with the exception of MCF-7.
Western blot analysis of whole cell lysates at 18, 24, 30 and 36 h after infection (data shown for 36 h) confirmed overexpression of E2F-1 and demonstrated upregulation of PKR levels in Ad5E2F-treated cells compared to controls (Figure 1 ). We noted slightly increased levels of PKR expression in Ad5Luc-treated cells compared to PBS-treated cells (presumably due to the nature of transgene transduction by the adenoviral vector). In the MDA-MB-468 cell line, upregulation of PKR was seen as early as 18 h after infection (data not shown). These cells showed signs of E2F-1-induced apoptosis earlier (at 24 h) than any of the other cell lines tested. PKR levels correlated with overexpression of E2F-1, and overexpression of PKR was visible in whole cell lysates from adherent cells as well as from floating cells, suggesting that the upregulation was not simply a late effect of apoptosis. MCF-7 cells were noted to have relatively high constitutive levels of PKR, and no significant upregulation of PKR was apparent in these cells following adenovirus-mediated E2F-1 overexpression.
E2F-1 induces PKR-mRNA upregulation
The promoter region of PKR includes an E2F binding site that matches the consensus E2F-1 sequence. We therefore evaluated whether adenovirus-mediated E2F-1 overexpression could upregulate PKR mRNA transcription. Real-time polymerase chain reaction (PCR) with Taqman probes allowed us to quantify the mRNA levels of Ad5E2F-, Ad5Luc-and PBStreated SW620 cancer cells. Indeed, 24 h after infection with E2F-1, PKR mRNA levels were increased to more than five times baseline (mock-infected) levels, whereas 24 h after infection with Ad5Luc, PKR mRNA levels were only twice baseline levels ( Figure 2 ). These findings support the hypothesis that E2F-1 binds to the promoter of PKR and directly upregulates PKR transcription, but they do not exclude that PKR mRNA is not indirectly upregulated via a second transcription factor.
E2F-1 induces upregulation of phosphorylated eIF-2a
To determine whether the upregulation of PKR resulted in activation of PKR and phosphorylation of downstream targets, we performed immunoblotting of protein from cells infected with Ad5E2F and controls that were lysed with additional phosphokinase inhibitor (orthovanadate). Phosphorylated eIF-2a was significantly upregulated in all cell lines tested with the exception of MCF-7 (only SW 620 cell-line is shown). Interestingly, phosphorylated eIF-2a could be verified to be significantly upregulated only in cells that were infected with Ad5E2F and not in cells infected with Ad5Luc despite the slight upregulation of phosphorylated PKR in luciferase-transduced cells (Figure 3) .
A chemical inhibitor of PKR reduces E2F-1-induced apoptosis
To determine whether Ad5E2F-mediated PKR upregulation and activation plays an essential role in E2F-1-induced apoptosis, we used the serine kinase inhibitor 2-aminopurine to chemically inhibit PKR activation and thereby block the induction of early downstream targets like eIF-2a (Mundschau and Faller, 1995; Zinn et al., 1988) . E2F-1-specific apoptosis was reduced by at least 50% in the cell lines tested (data not shown). Western blot analysis confirmed the dosedependent downregulation of phosphorylated eIF-2a by 2-aminopurine (Figure 4 ). These data indicate that programmed cell death initiated by overexpression of E2F-1 is at least partially dependent on the activation of PKR.
PKR-deficient MEFs are resistant to E2F-1-mediated apoptosis
To further evaluate the significance of PKR in the apoptotic response of cells overexpressing E2F-1, we utilized early-passage mouse embryo fibroblasts (MEFs) from PKR 7/7 and PKR +/+ mice that were continually tested to ensure that they had identical genetic backgrounds. Within 48 h after infection with Ad5E2F, almost 50% of PKR +/+ MEFs showed marked signs of apoptosis, whereas only a fraction of their PKR-deficient counterparts displayed morphologic changes consistent with apoptotic cell death ( Figure 5 ). In order to confirm that E2F-1 is functional in the PKR null cells, we used cell-cycle analysis by Fluorescence-activated cell sorter (FACS) of propidium iodide stained cells. The, although discrete, progression of fibroblasts into the S phase and to the G2/M checkpoint gives a hint that E2F-1 can still activate genes important for the overcoming of the G1-arrest. Thus a general inhibition of E2F-1 in cells lacking PKR is improbable ( Figure 5 ). FACS analysis confirmed apoptosis in more than 60% of Ad5E2F-treated PKR +/+ MEFs, but only 18% of Ad5E2F-treated PKR 7/7 MEFs ( Figure 6 ). This equals a 250% increase of susceptibility to E2F-1 induced apoptosis compared with Ad5Luc-induced apoptosis in PKR positive cells. To further exclude that the MEFs lacking PKR have a unspecific resistance to adenovirus mediated apoptotic genes, we infected the MEFs with an adenoviral vector that carried the strongly apoptotic Bax transgene under the control of a CMV promoter. Both PKR +/+ and PKR
7/7
MEFs displayed similar levels of apoptotic response after Ad5Bax treatment, ruling out an unspecific generally higher resistance to apoptosis in MEFs lacking the PKR gene (data not shown). 
E2F-1 does not directly interact with PKR
To further evaluate whether E2F-1 also directly interacts with PKR, we performed immunoprecipitation assays. Despite using a variety of PKR antibodies, we were not able to detect any binding of PKR to E2F-1 (data not shown). On fluorescence microscopy, cells undergoing apoptosis had E2F-1 overexpression as well as markedly upregulated PKR compared to luciferase-treated controls ( Figure 7 ). Consistent with previous reports, we found that E2F-1 was abundant in the nuclei of apoptotic cells whereas PKR was mostly localized in the cytoplasm. Further investigations with confocal fluorescence laser microscopy also confirmed that E2F-1 was abundant in nuclei whereas PKR was mostly localized in the cytoplasm (Figure 8 ).
NF-kB is not involved in the activation of PKR by E2F-1
PKR has previously been noted to interact either directly or indirectly with NF-kB. Therefore, we investigated the role of NF-kB in E2F-1-mediated apoptosis. Thirty-six hours after infection of cells with Ad5E2F or controls, the nuclear fraction of the cellular protein was collected and tested with a 32 P-labeled oligonucleotide of the DNA binding sequence of p65 (a subunit of NF-kB) by electrophoretic mobility shift assay. The gel-shift assay showed no difference in NFkB activity in the nucleus between Ad5E2F-treated and control-treated cells. A supershift assay with anti-p65 antibody in excess and a competition binding assay with cold (nonlabeled) oligonucleotide of the p65 binding-site sequence were performed and confirmed the specificity of binding (data not shown). These Figure 2 mRNA from SW 620 cells were extracted 24 h after treatment with Ad5E2F or controls. After reverse transcription the cDNA was amplified with a PKR-DNA complementary probe and GAPDH as internal control. Standard curves were assessed (not shown). Threshold value was set within the exponential amplification phase (linear phase in log scale) above the background noise (horizontal bar in PCR graph). After adjustment for GAPDH mRNA expression, real-time PCR demonstrated increased transcription of PKR mRNA in E2F-1-treated cells 24 h after infection findings suggest that in the cell lines tested, the antiapoptotic and anti-inflammatory pathway of NF-kB is not involved in E2F-1-mediated apoptosis.
Discussion
Apoptosis induced by overexpression of E2F-1
The initiation of DNA synthesis and the mediation of apoptosis are two distinct and separable functions of E2F-1 (Hsieh et al., 1997; Phillips et al., 1997) . The deregulation of this transcription factor can therefore induce proliferation or tumor suppressor function depending on the relative strengths of the apoptotic and proliferative responses generated. Several studies have demonstrated that adenovirus-mediated overexpression of E2F-1 induces programmed cell death in a wide variety of malignant cells (Hunt et al., 1997) . Whether p53 was required for E2F-1-mediated apoptosis was called into question when several authors proved that cancer cells with mutated p53 as well as cells with wild type p53 underwent apoptosis (Adams and Kaelin, 1996; Aktas et al., 1998; Field et al., 1996; Hsieh et al., 1997; Hunt et al., 1997; Kowalik et al., 1998; Phillips et al., 1997; Shan et al., 1996; Wang et al., 2000) . Further studies demonstrated that E2F-1-mediated induction of p14 ARF led to the stabilization of p53 and subsequently to apoptosis (Bates et al., 1998) . In contrast, the direct induction of p14 ARF resulted in growth arrest. This indicates that additional genes might be crucial in the apoptotic response to E2F-1 overexpression. Recently, it was shown that the p53 homologue p73 is involved in E2F-1-induced apoptosis and may partially compensate for loss of wild-type p53 (Irwin et al., 2000) . The demonstration of E2F-1-mediated inhibition of anti-apoptotic signals, such as NF-kB activation, provided a third possible pathway through which E2F-1 might sensitize cells to undergo apoptosis (Phillips et al., 1999; Rebollo et al., 2000) .
To determine the relevance of p53 and p73 in our model for E2F-1-induced apoptosis, we utilized different human cancer cell lines with or without mutations in p53 and with or without silenced p73. The MDA-MB-468 breast cancer cell line has mutated p53 and silenced p73; however, E2F-1-induced apoptosis was evident in these cells within 24 h after infection (Yoshikawa et al., 1999) . This demonstrates that neither wild-type p53 nor p73 was required for Ad5E2F-induced apoptosis.
Upregulation of PKR after Ad5E2F infection
PKR activation plays a fundamental role in defense against viruses by limiting replication and pathogenesis of viruses. Therefore, one would expect to see increased expression of PKR following gene transfer treatments that depend on viral vectors. We found that infection of tumor cells with replication-defective adenoviral vectors carrying the noncytotoxic luciferase reporter gene did indeed result in a slight increase in PKR expression levels compared to levels in PBS-treated (mock-infected) cells. However, after Ad5E2F treatment, PKR protein levels were markedly increased compared to PKR levels after Ad5Luc treatment in all cell lines tested except MCF-7.
PKR protein levels vary during the cell cycle, and a recent study suggested that PKR might play a role in cell cycle progression (Zamanian-Daryoush et al., 1999) . Zamanian-Daryoush and colleagues demon- With the commercially available phosphorylated PKR antibody a vast amount of protein had to be loaded to produce a visible band. This increased background noise and favored the less specific binding of the polyclonal antibody. Nevertheless, a slight increase of activated PKR compared to controls was noticeable. bactin controls show that the Luciferase band was probably somewhat overloaded, which additionally increased the phosphorylated PKR bands Figure 4 Western blot analysis of PKR and phosphorylated eIF2a 36 h after treatment with AdE2F, AdLuc at MOI 2000 vp/cell, or PBS: Inhibition of PKR activity with 2-aminopurine downregulated phosphorylated eIF-2a in a dose-dependent manner in Ad5E2F-treated cells, suggesting a specific PKR-dependent phosphorylation of eIF-2a. In order to visualize the downregulation of eIF-2a 50 mg of whole cell lysate had to be loaded. The clear appearance of a second PKR band could be related to the polyclonal antibody and the increased levels of protein loading strated that PKR mRNA and protein levels increased during the S phase, reaching a peak at the G2/M boundary, whereas PKR kinase activity exhibited two peaks, in early G1 phase and at the G1/S checkpoint, followed by a sharp decline in early S phase (Zamanian-Daryoush et al., 1999) . Studies utilizing mutant PKR suggested that PKR activity might be required for G1 and S progression and that PKR could play a role in phosphorylation of RB family members and E2F/DP proteins. It is known that E2F-1 induces the transcription of many genes required for S phase entry, and it cannot be ruled out that one of these genes might be involved in the phosphorylation of PKR in the early S phase when E2F is already downregulated (Dynlacht et al., 1994; Krek et al., 1994) . However, the finding that PKR protein levels, as well as levels of PKR's downstream substrate eIF2a, were significantly increased in Ad5E2F-treated cells that were already undergoing apoptosis (detached, floating cells), argues strongly against a nonspecific cell-cycle-dependent increase or activation of PKR.
Correlation between E2F-1-induced PKR upregulation and phosphorylation of downstream targets
PKR is regulated at both the transcriptional and posttranslational levels. RNA and proteins levels of PKR closely correlate, and a low level of latent PKR is found in most mammalian cells. The activity of PKR, however, is dependent on the homodimerization and autophosphorylation of PKR itself, which then phosphorylates its downstream targets, the most prominent being eIF-2a. The observed phosphorylation of eIF-2a after cells were treated with Ad5E2F is strong but indirect evidence that PKR is not only upregulated but also activated by E2F-1. Unfortunately, we were only to some extent able to demonstrate PKR phosphorylation with the currently available antibodies. Further evidence that PKR activity and not merely the PKR protein level is relevant in E2F-1-induced eIF-2a phosphorylation came in the form of the finding that cells pretreated with a potent protein inhibitor showed increased levels of phosphorylated eIF-2a but almost MEFs were consistent with apoptotic cell death. FACS analysis of the cell-cycle of propidium iodide stained MEFs at the same time-point showed progression of the fibroblasts from the resting G1-phase into S phase to the G2/M-checkpoint. These findings allow to suggest, that E2F-1 has not lost the control on genes important for the cell-cycle progression. Therefore a general inhibition of E2F-1 in PKR null MEFs can be excluded unchanged PKR levels after Ad5E2F or control vector infection.
Although the relationship between PKR and NF-kB has not been completely defined, PKR has been reported to be involved in the induction of NF-kB, a key regulator of cell survival. This regulation involves nonactivated, nondimerized PKR influencing the activity of IkB kinases, leading to the phosphorylation and subsequent degradation of IkB and eventually leading to the nuclear localization of NF-kB (Blair et al., 2001; Galabru et al., 1989; Gil et al., 2001; Ishii et al., 2001; Kumar et al., 1994 Kumar et al., , 1997 Rice et al., 1985) .
In our experiments, we tested for the nuclear localization of the NF-kB subunit p65 after Ad5E2F treatment. Even though one would assume that E2F-1-induced upregulation of PKR might interfere with IkBa, we could not find any difference in NF-kB activation in Ad5E2F-treated cells compared to controls. These findings are consistent with other reports demonstrating that E2F-1 overexpression might favor apoptotic responses due to inhibition of antiapoptotic signals like NF-kB (Klefstrom et al., 1997; Phillips et al., 1999) .
Induction of E2F-1-mediated apoptosis by PKR
One of the downstream targets of activated PKR is eIF2a, which is capable of mediating apoptosis by shutting off protein synthesis at the translation initiation level and hence shifting the protein balance of the cells towards apoptotic effectors (reviewed in Yoshikawa et al., 1999) . Recent findings showed additional pathways of PKR-dependent apoptosis with the involvement of the death receptors NF-kB or p53 (Balachandran et al., 1998; Yeung and Lau, 1998) . E2F-1-induced apoptosis has, indeed, been linked to p53 activation or to Figure 6 FACs analysis of propidium iodide stained MEFs: 36 h after treatment with Ad5E2F, apoptosis, quantitated by the percentage of cells with subdiploid DNA content (sub-G1 DNA, in PKR-deficient MEFs was significantly decreased compared to apoptotic cell death in PKR-wild-type MEFs. The lack of PKR seemed to render the fibroblast resistant to apoptosis induced by Ad5E2F treatment. Western blot analysis of whole cell lysate demonstrated similar levels of E2F-1 overexpression in both MEF cell lines and the absence of PKR protein expression in PKR 7/7 MEFs. Additionally, equal responsiveness of both MEFs to adenovirus mediated apoptotic genes was tested with an Ad5Bax vector, which induced equal percentage of apoptosis in PKR +/+ and PKR 7/7 MEF cells (data not shown) compensatory function of the p53 homologue p73, but in our study tumor cells with mutated p53 and silenced p73 readily underwent apoptosis after Ad5E2F infection. This is evidence for the existence of an additional p53/p73-independent pathway of E2F-1-induced apoptotic cell death (Figure 9 ). Chemical inhibition of PKR activation with 2-aminopurine resulted in at least 50% reduction of apoptosis induced by E2F-1. However, 2-aminopurine is known to inhibit the transcription of a number of cytokines, and it may interfere with other genes induced by E2F-1, mimicking the effect of selective PKR inhibition (Wathelet et al., 1989; Zinn et al., 1988) . Nevertheless, our finding that MEFs devoid of PKR showed striking resistance to Ad5E2F-induced cell death whereas MEFs expressing PKR readily underwent apoptosis strongly suggests that adenovirus-mediated overexpression of E2F-1 induces apoptosis in a PKR-dependent manner. We do not believe that PKR upregulation is due to the adenovirus alone since treatment with adenoviral vectors carrying the luciferase gene or any of a variety of strongly 
E2F-1 PKR staining
Confocal microscopy image of E2F-1 (red) and PKR (green) Figure 8 On confocal fluorescence microscopy in SW 620 cells, the different subcellular localization of E2F-1 (nucleus) and PKR (cytoplasm) 48 h after Ad5E2F treatment was evident. Only at the nuclear membrane was there evidence of a close relationship between the two proteins (indicated by the yellow areas). Direct interaction of E2F-1 and PKR at the nuclear membrane could not be verified by immunoprecipitation studies (data not shown)
apoptotic genes (p53, Bax, and Bak) did not result in the upregulation of PKR (data not shown). We are currently investigating possible interactions between E2F-1 and adenoviral vector genes.
Interestingly, one cell line tested (MCF-7) was resistant to apoptosis after Ad5E2F treatment. Despite upregulated E2F-1 and constitutively high levels of PKR, no eIF-2a activation could be demonstrated in MCF-7 cells. These findings are consistent with a recent report that MCF-7 contains an unknown transdominant inhibitor of PKR activation (Savinova et al., 1999) . To test the involvement of inhibitory factors, we measured protein levels of the cellular PKR inhibitor p58 IPK . No difference in p58 IPK levels between E2F-1-treated cells and controls was visible. Interestingly, the same results were found for MCF-7 cells, which do not undergo apoptosis following Ad5E2F treatment (data not shown). Deregulation of E2F-1 has the potential not only to drive cells into apoptosis but, depending on their state of differentiation and development, to induce cellular proliferation. It is interesting that there is evidence in the literature that PKR status may be an important regulator of tumorigenesis and that increased levels of PKR in lung and colon cancers are associated with improved survival (Haines et al., 1993; Jagus et al., 1999) . We are currently investigating whether the PKR-induced disturbance of the orchestrated balance between E2F-1-induced cell-cycle progression and eIF-2a-induced protein synthesis downregulation is the missing link that explains why Ad5E2F-treated cells ultimately undergo apoptosis.
Probable mechanism of E2F-1-induced PKR upregulation and activation
The increased PKR levels as measured by real-time PCR in early apoptotic cells suggest that E2F-1 induces PKR upregulation at the transcriptional level. This is consistent with findings from early studies that analysed the promoter region of PKR and demonstrated that adjacent to the PKR transcription start site is an interferon-stimulated response element sequence involved in the transcriptional induction of genes by type I interferon (Pellegrini and Schindler, 1993) . Overlapping the 5' portion of this PKR interferonstimulated response element is an E2F binding site that exactly matches the consensus E2F-1 sequence Samuel, 1994, 2000) . We are currently investigating the interactions between E2F-1 and the PKR promoter. Understanding these interactions, in addition to clarifying the downstream events will help to further elucidate the pathways of E2F-1-induced apoptosis.
Materials and methods
Cell lines and reagents
The human colon carcinoma cell lines SW480 and SW620 were obtained from American Type Culture Collection (ATCC: Manassas, VA, USA). The colon carcinoma cell line KM12L4 was kindly provided by Dr Lee M Ellis (M.D. Anderson Cancer Center, Houston, TX, USA). The MDA-MB-468 and MCF-7 human breast cancer cell lines were obtained from ATCC. MCF-7 cells have wild-type p53 and wild-type p73; SW480, SW620, and KM12L4 cells have mutated p53 and wild-type p73, and MDA-MB-468 cells have mutated p53 and silenced p73. Second-passage MEFs were obtained from Dr Glen N Barber (University of Miami School of Medicine, Miami, FL, USA). The genetic backgrounds of PKR 7/7 and PKR +/+ cells were verified to be identical. Cells were grown in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum supplemented with 2mM L-glutamine, 100 U/ml penicillin, and 100 mg/mg streptomycin. Cells were treated at a confluency of 75 to 85% 2-Aminopurine nitrate salt (Sigma Chemical Co; St. Louis, MO, USA) was used for the chemical inhibition of PKR activation.
Adenovirus
We used replication-deficient human type 5 adenovirus with the E1A region replaced with E2F-1 (Ad5E2F), the luciferase reporter gene (Ad5Luc), the b-galactosidase reporter gene (Ad5LacZ), the p53 gene (Ad5p53), the Bax gene (Ad5Bax), or the Bak gene (Ad5Bak). Adenoviral constructs were tested for E1A contamination using reverse transcriptase-polymerase chain reaction (RT -PCR). Electron microscopy of infected cells was used to confirm the lack of viral replication. Viral particles were measured using optical densitometry; plaque-forming assays using 293 cells were performed as described (Lieber et al., 1996) . A multiplicity of infection of 200 plaque-forming units per cell led to transduction of approximately 85 to 90% of the cells as determined by b-galactosidase expression following infection with Ad5LacZ. Figure 9 Shaded in grey is the novel pathway through which E2F-1 could mediate apoptosis. The finding that PKR plays a significant role in E2F-1-induced apoptosis adds additional complexity to the previously described mechanism of action of E2F-1. In our setting, death-receptor signaling or NF-kB activation probably does not play a crucial role
Flow cytometry analysis
We measured apoptotic cells using propidium iodide staining and FACS analysis. Supernatant and plated cells were harvested, pelleted by centrifugation, and resuspended in binding buffer (phosphate-buffered saline (PBS), 0.1% Triton X-100, and 0.1% sodium citrate) with a final propidium iodide concentration of 50 mg/ml. Cells were incubated at 48C for 16 h in the dark. Each sample was analysed in triplicate using FACS (FACScan, Becton-Dickinson, Mountain View, CA, USA; FL-3 channel). Subdiploid cells were considered apoptotic.
DNA fragmentation assay
DNA was isolated using a phenol-chloroform extraction procedure. The genomic DNA was analysed for degradation using gel electrophoresis. The agarose gels were photographed and examined for evidence of DNA oligonucleosomal fragmentation (DNA laddering), that confirms apoptosis.
Western blot analysis
Whole cell lysates were collected from adherent and floating cells after incubation of tissue culture with triple lysis buffer for 20 min at 48C and subsequent centrifugation at 14 000 r.p.m. Protein concentration was measured using the Bio-Rad assay (Bio-Rad, Hercules, CA, USA), and 20 mg protein was subjected to 10% sodium dodecyl sulfatepolyacrylamide gel electrophoresis and transferred to a nitrocellulose membrane. Antibodies used and their sources were as follows: E2F-1 (KH95), PKG (K-17), Bcl-2, Bak (N-20), Bax (P-19), TNF-R1 (H-271), TNF-a (H-156), TRADD (H-278), NF-kBp65 (sc-109), and p58 (Santa Cruz Biotechnology; Santa Cruz, CA, USA); phosphospecific PKR (pT451) and phosphospecific eIF-2a (pS51) (Bio Source International, Camarillo, CA, USA); cytochrome-C, caspase 3, caspase 8, and caspase 9 (PharMingen, San Diego, CA, USA); and b-actin (Sigma-Aldrich Chemicals, St. Louis, MO, USA). Membranes were then incubated with secondary horseradish peroxidase-conjugated antibodies (antigoat IgG, Santa Cruz Biotechnology; Santa Cruz, CA, USA; anti-rabbit and anti-mouse IgG; Sigma-Aldrich Chemicals) for 1 h at 48C. The membranes were developed according to Amersham's electrogenerated chemiluminescence protocol (Amersham, Arlington Heights, IL, USA).
Immunofluorescence and confocal fluorescence microscopy analysis
Cells (4610 5 cells/well) were grown on chamber slides overnight and treated with Ad5E2F-1, Ad5Luc, or PBS. Forty-eight hours later, cells were washed with PBS and fixed overnight in 4% paraformaldehyde. Cells were then permeabilized for 20 min at 48C with 0.2% Triton X-100 and blocked with 5% horse serum and 1% normal goat serum. Rabbit polyclonal anti-PKR (K-17) and mouse monoclonal anti-E2F-1 (KH95) were incubated overnight at 48C and developed with rhodamine or fluorescein-5-isothiocyanate goat anti-rabbit IgG for 30 to 45 min at 378C. Cells were then visualized under the fluorescence microscope and under the confocal microscope.
Electrophoretic mobility shift assay (EMSA)
Twenty-four hours after treatment with the adenovirus vectors, cells were collected and nuclear extracts were isolated according to the method described by Andrews and Faller (Andrews, 1991) . Twenty micrograms of extract was incubated with 1 mg of poly dI : dC (Amersham Pharmacia Biotech, Piscataway, NJ, USA) in binding buffer (75 mM NaCl, 15 mM Tris, 1.5 mM EDTA, 1.5 mM DTT, 25% glycerol, and 20 mg of bovine serum albumin) overnight at 48C. After 30 min incubation at room temperature with 32 Plabeled oligonucleotide probes containing the kB binding site (5'-CTCAACAGGGGA-CTTTCCGAGAG-GCCAT-3'), the reaction mixture was loaded onto a 6% polyacrylamide gel and run at 150 V. After vacuum-drying, the gel was analysed by autoradiography. The specificity of the oligonucleotide was proved by competition assay with unlabeled oligo-probe at 1006 excess; by supershift assay with p65 antibody; and by reversed supershift assay with p65 antibody and p65 peptide.
RT -PCR and real-time PCR
RT -PCR was carried out using the Thermoscript RT -PCR system kit according to the instructions provided by the manufacturer (Life Technologies, Gaithersburg, MD, USA). Total RNA was isolated according to the protocol for TRIzol extraction (Life Technologies), and 1 mg of each sample was reverse-transcribed to complementary DNA (cDNA) by a reaction containing 2 mM deoxynucleotide mix, 100 mM DTT, 40 units of RNase inhibitor, 50 ng of random primer, and 15 units of Thermoscript reverse transcriptase. The reaction was run at 258C for 10 min and at 508C for 50 min, heated at 858C for 5 min, and then cooled to 48C. To quantify the PKR mRNA expression, we used TaqMan PCR probes (Perkin Elmer Applied Biosystems, Foster, CA, USA) and the 7700 Sequence Detector (Perkin Elmer Applied Biosystems, Foster, CA, USA). Realtime PCR was performed using the protocol for TaqMan probes. Reactions contained 16 TaqMan Universal PCR Master Mix (Perkin Elmer Applied Biosystems, Foster, CA, USA), 900 nM forward primers (5'-CCTGTCCTCTGGTT-CTTTTGCT-3') and reverse primers (5'-GATGATTCA-GAAGCGAGTGTGC-3'), and 200 nM TaqMan probes (5'-ACGTGTGAGTCCCAAAGCAACTCTTTAGTGAC-3'). GAPDH primers and probes were added at 50 nM. Thermal cycling proceeded with 50 cycles of 958C for 15 s and 608C for 1 min. Input RNA amounts were calculated with relative standard curves for both the mRNAs of interest and GAPDH.
Statistical analysis
The data reported in the figures represent the mean of three or more independent experiments, and the bars show the standard deviation.
